Literature DB >> 10917163

CGRP-immunoreactive nerves in prurigo nodularis--an exploration of neurogenic inflammation.

Y Liang1, H H Jacobi, C M Reimert, M Haak-Frendscho, J A Marcusson, O Johansson.   

Abstract

BACKGROUND: The present study has explored the localization and distribution of calcitonin gene-related peptide (CGRP)-immunoreactive (IR) nerve fibers in prurigo nodularis, especially emphasizing its relationships to mast cells and eosinophils, which all are important contributors to inflammation.
METHODS: The exact localization of CGRP in the nerve fibers of prurigo nodularis lesional skin has been clarified by an ultrastructural immunogold labelling technique; and the relationships of CGRP-IR nerve fibers to tryptase-IR mast cells or eosinophil cationic protein (ECP)-IR eosinophils were also investigated by immunofluorescence double-labelling.
RESULTS: This ultrastructural study has demonstrated that CGRP immunoreactivity is increased in the dense-core vesicles in the axons of the prurigo nodularis lesional skin; the axons which contain CGRP are, in addition, enlarged and have more dense-core vesicles than the axons which do not contain CGRP. The immunofluorescence investigation demonstrated that tryptase-containing mast cells and ECP-containing eosinophils also are significantly increased in the lesional skin.
CONCLUSIONS: The results indicate that certain neurons increasingly express CGRP, which may dynamically result in a neurogenic inflammation in the lesional skin, through vasodilatation, and recruitment and regulation of inflammatory cells, e.g. eosinophils and mast cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10917163     DOI: 10.1034/j.1600-0560.2000.027007359.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  8 in total

Review 1.  Pruritus in allergy and immunology.

Authors:  Ting-Lin B Yang; Brian S Kim
Journal:  J Allergy Clin Immunol       Date:  2019-08       Impact factor: 10.793

2.  Dynamic mechanical allodynia following finger amputation: Unexpected skin hyperinnervation.

Authors:  Michelangelo Buonocore; Maria Concetta Gagliano; Cesare Bonezzi
Journal:  World J Clin Cases       Date:  2013-09-16       Impact factor: 1.337

Review 3.  Skin neurogenic inflammation.

Authors:  Jae Eun Choi; Anna Di Nardo
Journal:  Semin Immunopathol       Date:  2018-04-30       Impact factor: 9.623

4.  [Pathogenesis of prurigo nodularis].

Authors:  U Raap; C Günther
Journal:  Hautarzt       Date:  2014-08       Impact factor: 1.198

5.  Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune Polarization.

Authors:  Micah Belzberg; Martin Prince Alphonse; Isabelle Brown; Kyle A Williams; Raveena Khanna; Byron Ho; Shannon Wongvibulsin; Thomas Pritchard; Youkyung Sophie Roh; Nishadh Sutaria; Justin Choi; Jaroslaw Jedrych; Andrew D Johnston; Kakali Sarkar; Chirag Vasavda; Jimmy Meixiong; Carly Dillen; Kent Bondesgaard; John F Paolini; Wei Chen; David Corcoran; Nicolas Devos; Madan M Kwatra; Anna L Chien; Nathan K Archer; Luis A Garza; Xinzhong Dong; Sewon Kang; Shawn G Kwatra
Journal:  J Invest Dermatol       Date:  2021-03-23       Impact factor: 7.590

6.  The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case Series.

Authors:  Teresa Grieco; Vito Gomes; Alfredo Rossi; Carmen Cantisani; Maria Elisabetta Greco; Giovanni Rossi; Alvise Sernicola; Giovanni Pellacani
Journal:  J Clin Med       Date:  2022-07-31       Impact factor: 4.964

7.  Immunohistochemical Analysis of Prurigo Nodularis in 209 Patients: Clinicopathological Analysis between Atopic and Non-Atopic Patients and between Treatment Response Groups.

Authors:  Hyun Jeong Byun; Donghwi Jang; Dong-Youn Lee; Jun-Mo Yang
Journal:  Ann Dermatol       Date:  2021-07-01       Impact factor: 1.444

Review 8.  Pruritus as a Distinctive Feature of Type 2 Inflammation.

Authors:  Simone Garcovich; Martina Maurelli; Paolo Gisondi; Ketty Peris; Gil Yosipovitch; Giampiero Girolomoni
Journal:  Vaccines (Basel)       Date:  2021-03-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.